Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Veeva Systems's average EBITDA Per Share Growth Rate was 28.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 23.90% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 15.00% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 22.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Veeva Systems was 137.10% per year. The lowest was 3.70% per year. And the median was 29.30% per year.
Veeva Systems (NYSE:VEEV) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Veeva Systems 5-Year EBITDA Growth Rate Related Terms
VEEV vs BTSG, HQY, TEM: 5-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, Veeva Systems's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Veeva Systems's 5-Year EBITDA Growth Rate falls into.
Veeva Systems 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 15.00% mean?
Veeva Systems (VEEV) has a 5-Year EBITDA Growth Rate of 15.00% as of Jul. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Veeva Systems and its competitors.
Is Veeva Systems' 5-Year EBITDA Growth Rate too high?
Veeva Systems' current 5-Year EBITDA Growth Rate is 15.00%. Overall, Veeva Systems has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' 5-Year EBITDA Growth Rate compare to BTSG and HQY?
Veeva Systems' 5-Year EBITDA Growth Rate of 15.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Veeva Systems and its competitors. Veeva Systems's current 5-Year EBITDA Growth Rate is 15.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Fairly Valued. The stock's GF Value™ is $291.35, compared to a current price of $276.69 — trading 5% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 15.00%. Veeva Systems' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Veeva Systems (VEEV), the current 5-Year EBITDA Growth Rate is 15.00% as of Jul. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $276.69 is trading 5% below its estimated GF Value™ of $291.35.
GuruFocus considers Veeva Systems to be Fairly Valued.
Key valuation signals for VEEV:
5-Year EBITDA Growth Rate: 15.00%
GF Value™: $291.35 vs. price of $276.69 (5% below fair value)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
95GF Score
Get the complete analysis for VEEV
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
